{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T10:08:57Z","timestamp":1768126137543,"version":"3.49.0"},"reference-count":34,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2021,9,29]],"date-time":"2021-09-29T00:00:00Z","timestamp":1632873600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Cutaneous melanoma (CM) is the most aggressive form of skin cancer, and its worldwide incidence is rapidly increasing. Early stages can be successfully treated by surgery, but once metastasis has occurred, the prognosis is poor. However, some 5\u201310% of thick (\u22652 mm) melanomas do not follow this scenario and run an unpredictable course. Little is known about the factors that contribute to metastasis in some patient with thick melanomas and the lack thereof in thick melanoma patients who never develop metastatic disease. We were therefore interested to study differential gene expression and pathway analysis and compare non-metastatic and metastatic thick melanomas. We found that the TNF-like weak inducer of apoptosis (TWEAK) pathway was upregulated in thick non-metastasizing melanomas. MAP3K14 (NIK1), BIRC2 (cIAP1), RIPK1, CASP7, CASP8, and TNF play an important role in inhibiting proliferation and invasion of tumor cells via the activation of the non-canonical NF-\u03baB signaling pathway. In particular, this pathway sensitizes melanoma cells to TNF-alpha and activates the apoptosis module of the TWEAK pathway in thick non-metastasizing melanomas. Hence, our study suggests a potential role of the TWEAK pathway in inhibiting thick melanoma from metastasis. Exploitation of these genes and the pathway they control may open future therapeutic avenues.<\/jats:p>","DOI":"10.3390\/ijms221910568","type":"journal-article","created":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T00:03:42Z","timestamp":1632960222000},"page":"10568","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Road to Metastasis: The TWEAK Pathway as a Discriminant between Metastasizing and Non-Metastasizing Thick Melanomas"],"prefix":"10.3390","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7597-1720","authenticated-orcid":false,"given":"Canan","family":"G\u00fcven\u00e7","sequence":"first","affiliation":[{"name":"Department of Dermatology, University Hospitals Leuven, 3000 Leuven, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asier","family":"Antoranz","sequence":"additional","affiliation":[{"name":"Department of Imaging and Pathology, Translational Cell and Tissue Research, University Hospitals Leuven, 3000 Leuven, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5028-3422","authenticated-orcid":false,"given":"Anna","family":"Szumera-Cie\u0107kiewicz","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Maria Sklodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland"},{"name":"Diagnostic Hematology Department, Institute of Hematology and Transfusion Medicine, 02-776 Warsaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7304-714X","authenticated-orcid":false,"given":"Pawel P.","family":"Teterycz","sequence":"additional","affiliation":[{"name":"Department of Soft Tissue\/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8920-5429","authenticated-orcid":false,"given":"Piotr R.","family":"Rutkowski","sequence":"additional","affiliation":[{"name":"Department of Soft Tissue\/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert V.","family":"Rawson","sequence":"additional","affiliation":[{"name":"Melanoma Institute Australia, The University of Sydney, Sydney, NSW 2000, Australia"},{"name":"Faculty of Medicine and Health, Sydney Medical School, The University of Sydney, Sydney, NSW 2000, Australia"},{"name":"Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW 2000, Australia"},{"name":"NSW Health Pathology, Sydney, NSW 2000, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8991-0013","authenticated-orcid":false,"given":"Richard A.","family":"Scolyer","sequence":"additional","affiliation":[{"name":"Melanoma Institute Australia, The University of Sydney, Sydney, NSW 2000, Australia"},{"name":"Faculty of Medicine and Health, Sydney Medical School, The University of Sydney, Sydney, NSW 2000, Australia"},{"name":"Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW 2000, Australia"},{"name":"NSW Health Pathology, Sydney, NSW 2000, Australia"},{"name":"Charles Perkins Centre, The University of Sydney, Sydney, NSW 2000, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John F.","family":"Thompson","sequence":"additional","affiliation":[{"name":"Melanoma Institute Australia, The University of Sydney, Sydney, NSW 2000, Australia"},{"name":"Faculty of Medicine and Health, Sydney Medical School, The University of Sydney, Sydney, NSW 2000, Australia"},{"name":"Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Sydney, NSW 2000, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Newton-Bishop","sequence":"additional","affiliation":[{"name":"Institute of Medical Research at St James\u2019s, University of Leeds, Leeds LS2 9JT, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marguerite","family":"Stas","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, University Hospitals Leuven, 3000 Leuven, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veerle","family":"Boecxstaens","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, University Hospitals Leuven, 3000 Leuven, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0667-3284","authenticated-orcid":false,"given":"Oliver","family":"Bechter","sequence":"additional","affiliation":[{"name":"Department of General Medical Oncology, University Hospitals Leuven, 3000 Leuven, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0698-4736","authenticated-orcid":false,"given":"Jurgen","family":"Vercauteren","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Clinical and Epidemiological Virology, Katholieke Universiteit Leuven, 3000 Leuven, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marjan","family":"Garmyn","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University Hospitals Leuven, 3000 Leuven, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joost","family":"van den Oord","sequence":"additional","affiliation":[{"name":"Department of Imaging and Pathology, Translational Cell and Tissue Research, University Hospitals Leuven, 3000 Leuven, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8874-2003","authenticated-orcid":false,"given":"Francesca Maria","family":"Bosisio","sequence":"additional","affiliation":[{"name":"Department of Imaging and Pathology, Translational Cell and Tissue Research, University Hospitals Leuven, 3000 Leuven, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,9,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1111\/jdv.12236","article-title":"Trends in incidence and predictions of cutaneous melanoma across Europe up to 2015","volume":"28","author":"Arnold","year":"2014","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/bjc.2016.195","article-title":"Molecular characterisation of cutaneous melanoma: Creating a framework for targeted and immune therapies","volume":"115","author":"Rajkumar","year":"2016","journal-title":"Br. J. Cancer"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ccell.2015.03.001","article-title":"Immune checkpoint blockade: A common denominator approach to cancer therapy","volume":"27","author":"Topalian","year":"2015","journal-title":"Cancer Cell"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3322\/caac.21409","article-title":"Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual","volume":"67","author":"Gershenwald","year":"2017","journal-title":"CA Cancer J. Clin."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1046\/j.1365-2559.1998.00523.x","article-title":"Analysis of histopathological factors associated with prolonged survival of 10 years or more for patients with thick melanomas (>5 mm)","volume":"33","author":"Spatz","year":"1998","journal-title":"Histopathology"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1365-2559.1991.tb01456.x","article-title":"Thick malignant melanomas (greater than 3 mm Breslow) with good clinical outcome: A histological study and survival analysis","volume":"18","author":"Blessing","year":"1991","journal-title":"Histopathology"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1038\/jid.2014.452","article-title":"More people die from thin melanomas (1 mm) than from thick melanomas (>4 mm) in Queensland, Australia","volume":"135","author":"Whiteman","year":"2015","journal-title":"J. Invest. Dermatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"933","DOI":"10.18632\/aging.100951","article-title":"MMP-9 overexpression is associated with intragenic hypermethylation of MMP9 gene in melanoma","volume":"8","author":"Falzone","year":"2016","journal-title":"Aging"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1007\/s13277-012-0480-6","article-title":"The role of CCND1 alterations during the progression of cutaneous malignant melanoma","volume":"33","author":"Vizkeleti","year":"2012","journal-title":"Tumour Biol."},{"key":"ref_10","unstructured":"The Cancer Genome Atlas Network (2015). Genomic Classification of Cutaneous Melanoma. Cell, 161, 1681\u20131696."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"21546","DOI":"10.1074\/jbc.M110.203745","article-title":"TWEAK induces apoptosis through a death-signaling complex comprising receptor-interacting protein 1 (RIP1), Fas-associated death domain (FADD), and caspase-8","volume":"286","author":"Ikner","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1083\/jcb.200801010","article-title":"TWEAK-FN14 signaling induces lysosomal degradation of a cIAP1-TRAF2 complex to sensitize tumor cells to TNFalpha","volume":"182","author":"Vince","year":"2008","journal-title":"J. Cell Biol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"376470","DOI":"10.1155\/2012\/376470","article-title":"A Bioinformatics Resource for TWEAK-Fn14 Signaling Pathway","volume":"2012","author":"Bhattacharjee","year":"2012","journal-title":"J. Signal Transduct."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"7424","DOI":"10.1158\/1078-0432.CCR-18-3659","article-title":"Transcriptomic Analysis Reveals Prognostic Molecular Signatures of Stage I Melanoma","volume":"25","author":"Thakur","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"ref_15","unstructured":"Raw mRNA Expressions (2021, May 10). The Leeds Melanoma Cohort Gene Expression Data Access Committee. Available online: https:\/\/ega-archive.org\/datasets\/EGAD00010001562."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1111\/j.1600-0625.2006.00502.x","article-title":"Oestrogen receptorbeta expression in melanocytic lesions","volume":"15","author":"Schmidt","year":"2006","journal-title":"Exp. Dermatol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4137\/GEG.S31264","article-title":"Estrogen Receptor Alpha (ESR1) Single-Nucleotide Polymorphisms (SNPs) Affect Malignant Melanoma Susceptibility and Disease Course","volume":"8","author":"Glatthaar","year":"2016","journal-title":"Genet Epigenet."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"81474","DOI":"10.18632\/oncotarget.13034","article-title":"TWEAK activation of the non-canonical NF-kappaB signaling pathway differentially regulates melanoma and prostate cancer cell invasion","volume":"7","author":"Armstrong","year":"2016","journal-title":"Oncotarget"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Gu, L., Dai, L., Cao, C., Zhu, J., Ding, C., Xu, H.-B., Qiu, L., and Di, W. (2013). Functional expression of TWEAK and the receptor Fn14 in human malignant ovarian tumors: Possible implication for ovarian tumor intervention. PLoS ONE, 8.","DOI":"10.1371\/annotation\/aa15cad6-0a7a-4b4e-ac1b-b24af35b723c"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"8968","DOI":"10.1158\/0008-5472.CAN-04-1879","article-title":"Soluble tumor necrosis factor-like weak inducer of apoptosis overexpression in HEK293 cells promotes tumor growth and angiogenesis in athymic nude mice","volume":"64","author":"Ho","year":"2004","journal-title":"Cancer Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.bbrc.2004.04.084","article-title":"Functional expression of TWEAK in human hepatocellular carcinoma: Possible implication in cell proliferation and tumor angiogenesis","volume":"318","author":"Kawakita","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_22","first-page":"87","article-title":"Functional expression of TWEAK in human colonic adenocarcinoma cells","volume":"26","author":"Kawakita","year":"2005","journal-title":"Int. J. Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1245\/s10434-011-1825-x","article-title":"Prognostic significance of TWEAK expression in colorectal cancer and effect of its inhibition on invasion","volume":"19","author":"Lin","year":"2012","journal-title":"Ann. Surg. Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3892\/etm.2010.181","article-title":"Therapeutic potential of the TWEAK\/Fn14 pathway in intractable gastrointestinal cancer","volume":"2","author":"Yoriki","year":"2011","journal-title":"Exp. Ther. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cyto.2007.09.007","article-title":"TWEAKing tissue remodeling by a multifunctional cytokine: Role of TWEAK\/Fn14 pathway in health and disease","volume":"40","author":"Burkly","year":"2007","journal-title":"Cytokine"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1158\/1541-7786.MCR-09-0194","article-title":"Tumor necrosis factor-like weak inducer of apoptosis stimulation of glioma cell survival is dependent on Akt2 function","volume":"7","author":"Fortin","year":"2009","journal-title":"Mol. Cancer Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"5826","DOI":"10.1038\/sj.emboj.7601441","article-title":"TWEAK, via its receptor Fn14, is a novel regulator of mesenchymal progenitor cells and skeletal muscle regeneration","volume":"25","author":"Girgenrath","year":"2006","journal-title":"Embo J."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"8455","DOI":"10.1074\/jbc.274.13.8455","article-title":"TWEAK induces angiogenesis and proliferation of endothelial cells","volume":"274","author":"Lynch","year":"1999","journal-title":"J. Biol. Chem."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1038\/s41388-020-01584-6","article-title":"STAT3 promotes melanoma metastasis by CEBP-induced repression of the MITF pathway","volume":"40","author":"Swoboda","year":"2020","journal-title":"Oncogene"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1200\/JCO.2009.23.4799","article-title":"Final version of 2009 AJCC melanoma staging and classification","volume":"27","author":"Balch","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: Ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","article-title":"The Sequence Alignment\/Map format and SAMtools","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"4378","DOI":"10.1093\/nar\/gkt111","article-title":"Enriching the gene set analysis of genome-wide data by incorporating directionality of gene expression and combining statistical hypotheses and methods","volume":"41","author":"Varemo","year":"2013","journal-title":"Nucleic Acids Res."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/19\/10568\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:07:37Z","timestamp":1760166457000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/19\/10568"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,29]]},"references-count":34,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2021,10]]}},"alternative-id":["ijms221910568"],"URL":"https:\/\/doi.org\/10.3390\/ijms221910568","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,29]]}}}